Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine

Mahesh Shrestha, Michael J. Chiu, Robert L. Martin, John J. Cush, Michael S. Wainscott

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Nine consecutive patients presenting with acute gouty arthritis were treated with ketorolac 60 mg Intramuscularly (IM). The average age was 58. Seven were male, and six were black. Pain was quantified in 6 of the patients using a 10-cm visual analog scale that the patients compieted before and 30, 60, and 90 minutes after ketorolac administration. The mean pain score (± standard error of the mean) dropped from 6.43 (±1.25), out of a possible 10, to 1.01 (±.35) (P < .01). There were no side effects of the medication. All of the patients were able to leave the treatment area satisfied with their treatment. None of the patients required crutches at discharge.

Original languageEnglish (US)
Pages (from-to)454-455
Number of pages2
JournalAmerican Journal of Emergency Medicine
Issue number4
StatePublished - Jul 1994


  • Gout
  • gouty arthritis
  • ketorolac
  • pain scale

ASJC Scopus subject areas

  • Emergency Medicine


Dive into the research topics of 'Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine'. Together they form a unique fingerprint.

Cite this